New: Amy Gleason was the acting administrator of DOGE as it worked to slash the size of the federal workforce through layoffs and incentivizing employees to quit.
Her husband got hired at an under-the-radar division of HHS just 33 days after widespread layoffs at the agency
🎁: https://t.co/fW7wTOshPy
New: Following yesterday’s news about ARPA-H Director Alicia Jackson, agency leaders briefed staff about her absence and the remaining ethics issues.
Story w/ @rachelcohrs
https://t.co/2eMP0ujN0r
“We’ve got to make sure that that process is in place. We’re working really hard to do it,” Kyle Diamantas, acting FDA commissioner, said Monday about the agency's rare disease initiative framework. “It’s a top priority of mine.” https://t.co/YsoJzZWLjH
New from me on the campaign trail!
Visited Lansing, Mich., last week to shadow @tombarrettmi7 as he door-knocked & @WeWill2026 as he held town halls.
It's the costliest House race in the country & both men are leaning into populist health policy ideas.
https://t.co/7egH6MF4j1
New: Top officials at HHS and FDA have been working to balance Health Secretary Robert F. Kennedy Jr.’s push to expand access to buzzy peptides with safety concerns raised by agency scientists. A peek behind the curtain with new details on the path ahead w/ the dream team @rileyraygriffin@g0ingmad@nyahphengsitthy
🎁: https://t.co/bjp3szklJd
The Federal Labor Relations Authority cautioned HHS about using AI in briefs after finding discrepancies in a majority of citations and footnotes in a recent brief.
https://t.co/mOia2LAlc9
The Trump administration is rolling out seismic changes to federal performance evaluations — and workers say they are already eroding morale and diminishing managers’ input. https://t.co/kS8aioYiDB
New: FDA leadership is kicking off a top-to-bottom review of how it approaches approvals for drugs to treat rare diseases. The Rare Disease Framework Initiative will kick off with a meeting on Oct. 28
w/ @RobertLangreth
🎁: https://t.co/e3Sp5I126H
First in @BLaw: The leading hospital trade association is challenging the government’s renewed attempt at a 340B drug rebate pilot slated to run early next year, seeking to derail the new discount mechanism for the second time. https://t.co/nuGHVRTvNE
Abortion providers are facing a loss of legal protections when offering services to out-of-state patients under a legal challenge that threatens to upend reproductive rights.
https://t.co/FGZo14shJq
A three-judge panel mulled Tuesday what authority it has to review RFK Jr.'s appointments to a federal vaccine advisory panel, weighing whether it will overturn an order suspending the hand-picked selections. https://t.co/KNisM5VR1i
New: Likely Louisiana senator-to-be Julia Letlow is already thinking about her health priorities for 2027, which include implementing a universal breast cancer risk assessment.
It’s personal for Letlow, who shared she had a double mastectomy 3 years ago.
https://t.co/Q8kCSmP2lB